Abstract:Five new type binuclear platinum(II) complexes (a–e) have been synthesized and characterized by elemental analysis, conductivity, thermal analysis, IR, UV, 1H NMR and mass spectral techniques. The cytotoxicity of the complexes was tested by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and sulforhodamine B (SRB) assays. The acute toxicity and antitumor activity of complex e in vivo were also studied. The results indicate that complexes a–d have no activity against HL-60, MCF-7, BGC-823, EJ and HCT-8 cell lines, with a higher IC50 value (>50μM). Complex e confers substantially greater cytotoxicity against HL-60, MCF-7, BGC-823, EJ and HCT-8 cell lines with an IC50 value of 0.02±0.009, 1.70±0.21, 4.00±0.35, 0.98±0.02 and 1.02±0.21μM, respectively. LD50 of complex e is 815.3mg/kg, it was significantly higher than that of cisplatin and carboplatin. Complex e at dose of 4, 12 and 20mg/kg has no activity against mouse hepatocarcinoma H22 and Lewis lung carcinoma in mice, but displays significant activity against human ovarian carcinoma A2780 and human colon carcinoma HCT-116 in nude mice at dose of 12mg/kg, and activity is similar to that of cisplatin at dose of 4mg/kg. Complex e at dose of 20mg/kg has no activity against human lung adenocarcinoma A549 in nude mice (P>0.05). The results suggest that the species of amine for the new type binuclear platinum complexes have important effect on their cytotoxicity, and they may be a new class platinum anticancer drugs.

Synthesis, Cytotoxicity, and Apoptosis Induction Study of Antitumor Dinuclear Platinum(ii) Complexes.

Synthesis, characterization, and cytotoxicity of new types of binuclear platinum(II) complexes

Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.

Synthesis, Cytotoxicity, Induction of Apoptosis, and Interaction with DNA of Dinuclear Platinum(II) Complexes

Design, Synthesis and in Vitro Cytotoxicity of Novel Dinuclear Platinum(Ii) Complexes

Novel antitumor dinuclear platinum (II) complexes with a new chiral tetradentate ligand as the carrier group

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Synthesis and Antitumor Activity of Dinuclear Platinum Complexes with (1(i)R, 1(ii)R, 2(i)R, 2(ii)R)-N-i,N-ii-(1, 3-Phenylenebis(methylene))dicyclohexane-1, 2-diamie as the Ligand

Antitumor dinuclear platinum(II) complexes derived from a novel chiral ligand.

Synthesis, Characterization and Biological Evaluation of Platinum(II) Complexes with a Chiral N-Monosubstituted 1,2-Cyclohexyldiamine Derivative

Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.

Synthesis and in Vitro Cytotoxicity of Novel Hydrophilic Chiral 2-Alkoxy-1,4-butanediamine Platinum (II) Complexes.

Synthesis and Biological Evaluation of Platinum(ii) Complexes Containing (1R,2r)-N1-alkyl-1,2-diaminocyclohexane and D-(+)-camphorate Ligands

Synthesis and Cytotoxic Evaluation of Novel Platinum(Ii) Complexes with C2-Asymmetric and C2-Symmetric Chiral Vicinal Diamines

Study on the Cytotoxic Activity of Platinum(ii) Complexes of (1 R ,2 R )- N 1 -Cyclopentyl-1,2-cyclohexanediamine with Substituted Malonate Derivatives

Synthesis, Reactivity Studies and Cytotoxicity of Two Iodidoplatinum(II) Complexes. Does Photoactivation Work?

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

THE SYNTHESIS AND CHARACTERIZATION OF DINUCLEAR PLATINUM COMPLEXES BRIDGED BY DIPYRIDYL SELENIDES OR SULFIDES

Synthesis and in Vitro Cytotoxicity of Platinum(Ii) Complexes with Chiral N-Monosubstituted 1,2-Cyclohexyldiamine Derivatives As the Carrier Groups

Synthesis, Characterization and Antitumor Activity of New Type Binuclear Platinum(ii) Complexes.

Synthesis, invitro Cytotoxicity, and Interaction with DNA of Platinum(II) Complexes with N-Monocycloalkyl Derivatives of 1R,2R-Diaminocyclohexane as Carrier Ligands